This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gurlek, A. Articles by Kumar, R. Search for Related Content PubMed PubMed Citation Articles by Gurlek, A. Articles by Kumar, R. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB 1,25-DIHYDROXYCHOLECALCIFEROL

Modulation of Growth Factor/Cytokine Synthesis and Signaling by 1,25-Dihydroxyvitamin D₃: Implications in Cell Growth and Differentiation

Departments of Medicine (A.G., R.K.), Dermatology (M.R.P.), and Biochemistry and Molecular Biology (M.R.P., R.K.), Mayo Clinic and Foundation, Rochester, Minnesota 55905

Correspondence: Address all correspondence and requests for reprints to: Rajiv Kumar, M.D., Departments of Medicine, Biochemistry and Molecular Biology, Mayo Clinic and Foundation, 200 First Street SW, 911A Guggenheim Building, Rochester, Minnesota 55905. E-mail: rkumar{at}mayo.edu

Distinct from its classic functions in the regulation of calcium and phosphorus metabolism as a systemic hormone, 1,25-dihydroxyvitamin D₃ [1,25(OH)₂D₃] is involved in the local control and regulation of cellular growth and differentiation in various tissues, including epidermis (keratinocytes) and bone (osteoblasts and osteoclasts). In this review, the impact of 1,25(OH)₂D₃ on growth factor/cytokine synthesis and signaling is discussed, particularly as it pertains to bone cells and keratinocytes. 1,25(OH)₂D₃ not only regulates growth factor/cytokine synthesis but may also alter growth factor signaling. Recently discovered examples for such interactions are the interactions between the vitamin D receptor and the mothers against decapentaplegic-related proteins that function downstream of TGFß receptors. Inhibitory effects of 1,25(OH)₂D₃ on keratinocytes through TGFß activation and IL-1, IL-6, and IL-8 suppression may provide a rationale for its beneficial effects in the treatment of hyperproliferative skin disorders, whereas stimulatory effects through the epidermal growth factor-related family members and platelet-derived growth factor may be operative in its beneficial effects in skin atrophy and wound healing. Modulation of cytokines and growth factors by 1,25(OH)₂D₃ during bone remodeling plays an important role in the coupling of osteoblastic bone formation with osteoclastic resorption to maintain bone mass.

This article has been cited by other articles:

				A. Moeenrezakhanlou, L. Shephard, L. Lam, and N. E. Reiner Myeloid cell differentiation in response to calcitriol for expression CD11b and CD14 is regulated by myeloid zinc finger-1 protein downstream of phosphatidylinositol 3-kinase J. Leukoc. Biol., August 1, 2008; 84(2): 519 - 528. [Abstract] [Full Text] [PDF]

				F. Tokmak, I. Quack, G. Schieren, L. Sellin, D. Rattensperger, T. Holland-Letz, S. M. Weiner, and L. C. Rump High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients Nephrol. Dial. Transplant., July 1, 2008; (2008) gfn367v1. [Abstract] [Full Text] [PDF]

				K. Ng, J. A. Meyerhardt, K. Wu, D. Feskanich, B. W. Hollis, E. L. Giovannucci, and C. S. Fuchs Circulating 25-Hydroxyvitamin D Levels and Survival in Patients With Colorectal Cancer J. Clin. Oncol., June 20, 2008; 26(18): 2984 - 2991. [Abstract] [Full Text] [PDF]

				J. C. McCann and B. N. Ames Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? FASEB J, April 1, 2008; 22(4): 982 - 1001. [Abstract] [Full Text] [PDF]

				L. J. Schedlich, A. Muthukaruppan, M. K. O'Han, and R. C. Baxter Insulin-Like Growth Factor Binding Protein-5 Interacts with the Vitamin D Receptor and Modulates the Vitamin D Response in Osteoblasts Mol. Endocrinol., October 1, 2007; 21(10): 2378 - 2390. [Abstract] [Full Text] [PDF]

				J. Sun, J. Kong, Y. Duan, F. L. Szeto, A. Liao, J. L. Madara, and Y. C. Li Increased NF-{kappa}B activity in fibroblasts lacking the vitamin D receptor Am J Physiol Endocrinol Metab, August 1, 2006; 291(2): E315 - E322. [Abstract] [Full Text] [PDF]

				J. Kong, S. A. Grando, and Y. C. Li Regulation of IL-1 Family Cytokines IL-1{alpha}, IL-1 Receptor Antagonist, and IL-18 by 1,25-Dihydroxyvitamin D3 in Primary Keratinocytes J. Immunol., March 15, 2006; 176(6): 3780 - 3787. [Abstract] [Full Text] [PDF]

				T.-T. Wang, L. E. Tavera-Mendoza, D. Laperriere, E. Libby, N. Burton MacLeod, Y. Nagai, V. Bourdeau, A. Konstorum, B. Lallemant, R. Zhang, et al. Large-Scale in Silico and Microarray-Based Identification of Direct 1,25-Dihydroxyvitamin D3 Target Genes Mol. Endocrinol., November 1, 2005; 19(11): 2685 - 2695. [Abstract] [Full Text] [PDF]

				X. Zhang, P. Li, J. Bao, S. V. Nicosia, H. Wang, S. A. Enkemann, and W. Bai Suppression of Death Receptor-mediated Apoptosis by 1,25-Dihydroxyvitamin D3 Revealed by Microarray Analysis J. Biol. Chem., October 21, 2005; 280(42): 35458 - 35468. [Abstract] [Full Text] [PDF]

				A. L. M. Sutton, X. Zhang, T. I. Ellison, and P. N. MacDonald The 1,25(OH)2D3-Regulated Transcription Factor MN1 Stimulates Vitamin D Receptor-Mediated Transcription and Inhibits Osteoblastic Cell Proliferation Mol. Endocrinol., September 1, 2005; 19(9): 2234 - 2244. [Abstract] [Full Text] [PDF]

				M. Galindo, J. Pratap, D. W. Young, H. Hovhannisyan, H.-J. Im, J.-Y. Choi, J. B. Lian, J. L. Stein, G. S. Stein, and A. J. van Wijnen The Bone-specific Expression of Runx2 Oscillates during the Cell Cycle to Support a G1-related Antiproliferative Function in Osteoblasts J. Biol. Chem., May 27, 2005; 280(21): 20274 - 20285. [Abstract] [Full Text] [PDF]

				D. M. Harris and V. L. W. Go Vitamin D and Colon Carcinogenesis J. Nutr., December 1, 2004; 134(12): 3463S - 3471S. [Abstract] [Full Text] [PDF]

				O. Morales, M. K. R. Samuelsson, U. Lindgren, and L.-A. Haldosen Effects of 1{alpha},25-Dihydroxyvitamin D3 and Growth Hormone on Apoptosis and Proliferation in UMR 106 Osteoblast-Like Cells Endocrinology, January 1, 2004; 145(1): 87 - 94. [Abstract] [Full Text] [PDF]